[9] |
Buchbinder M,Solar R.Targeted vascular drug delivery.A new day for an old way[J].Panminerva Med,2013,55(4):353-361.
|
[1] |
ZhuM,YangM,LinJ,etal.Associationofsevenreninangiotensin system gene polymorphisms with restenosis in patients following coronary stenting[J].J Renin-Angiotensin-Aldost Sy,2017,18(1):1-9.
|
[2] |
Bassous N,Cooke JP,Webster TJ.Enhancing Stent Effectiveness with Nanofeatures[J].Methodist Debakey Cardiovasc J,2016,12(3):163-168.
|
[3] |
Kim YH,Lee JH,Roh JH,et al.Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis[J].Jacc Cardiovasc Interv,2015,8(4):550-560.
|
[4] |
Sotomi Y,Onuma Y,Collet C,et al.Bioresorbable scaffold:the emerging reality and future directions[J].Circ Res,2017,120(8):1341-1352.
|
[5] |
Alt E,Haehnel I,Beilharz C,et al.Inhibition of neointima formation after experimental coronary artery stenting:a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost[J].Circulation,2000,101(12):1453-1458.
|
[6] |
Ancona MB,Tanaka A,Latib A,et al.Restored physiological vasomotion imitating intrascaffold restenosis 3 years after bioresorbable scaffold implantation[J].Can J Cardiol Home,2016,32(12):e9-e10.
|
[7] |
Murata N,Takayama T,Hiro T.Serial observations of instent restenosis treated with drug-coated balloon angioplasty by optical coherence tomography and coronary angioscopy[J]. Int Heart J,2017,58(1):134-139.
|
[8] |
Roubin GS,Gruentzig AR.Percutaneous transluminal coronary angioplasty:state of the art and future directions[J].Int J Cardiac Imaging,1985,1(2):143-154.
|
[10] |
Kalra A,Rehman H,Khera S,et al.New-Generation coronary stents:current data and future directions[J].Curr Atheroscler Rep,2017,19(3):14.
|
[11] |
Codner P,Gurm HS,Motivala A.Coronary stents in diabetic patients:state of the knowledge[J].Curr Cardiol Rep,2017,19(4):28.
|
[12] |
Jinnouchi H,Kuramitsu S,Shinozaki T,et al.Difference of tissue characteristics between early and late restenosis after second-generation drug-eluting stents implantation-an optical coherence tomography study[J].Circ J,2017,81(4):450-457.
|
[13] |
Burzotta F,Leone AM,Demaria GL,et al.Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty(FORZA)trial:study protocol for a randomized controlled trial[J].Trials,2014,15(1):1-9.
|
[14] |
Malik N,Banning AS,Belger M,et al.A risk scoring system to predict coronary stent thrombosis[J].Curr Med Res Opin,2017,33(5):859-867.
|
[15] |
Gabbasov Z,Kozlov S,Byazrova S,et al.Blood level of CD45+platelets and development of restenosis after drugeluting stent implantation in patients with stable coronary artery disease[J].Wien Klin Wochenschr,2016,128(23-24):898-905.
|
[16] |
Shah P,Vasudev R,Abuarqoub AH,et al.Cocaine-induced very late stent thrombosis[J].BMJ Case Reports,2016:2016. [17]Hsieh MJ,Huang YC,Yeh JK,et al.Predictors of longterm outcomes after drug-eluting balloon angioplasty for bare-metal stent restenosis[J].Heart,lung circ,2017.
|
[18] |
Kang YH,Lao HY,Yu XY,et al.Progress in genetic and epigenetic research on in-stent restenosis after percutaneous coronary interventions[J].Chin J Med Genet,2012,29(1):38-42.
|